XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study Read more about XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study
Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C Read more about Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C
Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life Read more about Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life
A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM) Read more about A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)
A Prospective Multicentre Randomised Controlled Trial of Early Goal Directed Sedation Compared with Standard Care in Mechanically Ventilated Patients in Intensive Care Read more about A Prospective Multicentre Randomised Controlled Trial of Early Goal Directed Sedation Compared with Standard Care in Mechanically Ventilated Patients in Intensive Care
Global Registry Program on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation. Read more about Global Registry Program on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation.
Prevalence and Patient Experience with Condylomas Study in Saudi Arabia Read more about Prevalence and Patient Experience with Condylomas Study in Saudi Arabia
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study Read more about A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial) Read more about Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial)
Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi Read more about Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi